AKIGAI

AKIGAI

@www.akigai.no

Oslo
https://www.akigai.no/
Biotechnology Research

Overview

About AKIGAI

We have an obligation. Because we have witnessed the effects again and again. Like many breakthrough discoveries in medicine, the understanding that relief of neuropathic pain was a result of EGFR inhibition came serendipitously.

Headquarters

Oslo

Website

https://www.akigai.no/

Company Size

2-10 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2025

Specialties

Neuropathic pain, EGFR inhibitors, Biotech, and Drug development

Posts